Related Experiment Video
Updated: May 24, 2026

Robot-Assisted Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma
Published on: December 15, 2023
Expression of Ras-related C3 botulinum toxin substrate 1 (RAC1) in human cholesteatoma
No Hee Lee1, Ji-Won Chang, June Choi
1Department of Otolaryngology-Head and Neck Surgery, Korea University College of Medicine, 126-1 Anam-dong 5-Ga, Seongbuk-Gu, Seoul 136-705, South Korea. lnhkk@hanmail.net
Abstract:
Ras-related C3 botulinum toxin substrate 1 (RAC1) is a 21-kDa signaling G protein that functions as a pleiotropic regulator of many cellular processes including epithelial differentiation. RAC1 activates the nicotinamide adenine dinucleotide phosphate oxidase complex which promotes formation of reactive oxygen species and degradation enzymes. RAC1 has been associated with rapid epithelial differentiation and invasive properties in human cholesteatoma. This study aimed to identify the presence of RAC1 in human cholesteatoma and analyze its functional role as a regulator of proteolysis and overgrowth. Tissue samples from human cholesteatoma and normal postaural skin were obtained from patients during otologic surgery for cholesteatoma. The expression of RAC1 mRNA was quantified by real-time RT-PCR, and localization of RAC1 expression was confirmed using immunohistochemical staining. Expression of RAC1 mRNA in the epithelium of cholesteatoma was significantly elevated 2.94 fold on average, compared with normal control skin. RAC1 expression in the suprabasal and basal layer of cholesteatoma epithelium was stronger than normal control skin. Our results suggest that RAC1 can be associated with rapid epithelial differentiation and invasive properties of human cholesteatoma.
Insights
Ras-related C3 botulinum toxin substrate 1 (RAC1) is elevated in human cholesteatoma, promoting rapid epithelial differentiation and invasive properties. This signaling G protein plays a key role in cholesteatoma overgrowth and proteolysis.
Area of Science:
- Cellular Biology
- Molecular Biology
- Otolaryngology
Background:
- Ras-related C3 botulinum toxin substrate 1 (RAC1) is a signaling G protein regulating cellular processes like epithelial differentiation.
- RAC1 activation of NADPH oxidase generates reactive oxygen species and degradation enzymes, linked to epithelial invasiveness.
Purpose of the Study:
- To identify RAC1 presence in human cholesteatoma.
- To analyze RAC1's role in regulating proteolysis and overgrowth in cholesteatoma.
Main Methods:
- Quantitative real-time RT-PCR to measure RAC1 mRNA expression.
- Immunohistochemical staining to localize RAC1 expression.
- Analysis of tissue samples from human cholesteatoma and normal postaural skin.
Main Results:
- RAC1 mRNA expression was significantly elevated (2.94-fold average) in cholesteatoma epithelium compared to normal skin.
- RAC1 expression was notably stronger in the suprabasal and basal layers of cholesteatoma epithelium.
Conclusions:
- RAC1 is significantly upregulated in human cholesteatoma.
- RAC1 is associated with the rapid epithelial differentiation and invasive characteristics of cholesteatoma.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Abnormal Proliferation

